The product is approved for the treatment of Bovine Respiratory Disease (BRD) associated with Mannheimia haemolytica, Pasteurella multocida, and Histophilus somnus in beef and non-lactating dairy cattle.
The global veterinary pharmaceutical company says the new BRD treatment antibiotic has the same active ingredient and formulation as Baytril 100 (enrofloxacin) and is approved in cattle for multi-day use only.
It will be available from veterinarians in 100 mL and 250 mL bottles to fit any size operation.
—From Norbrook news release
